Purpose: To develop a numerical approach for estimation of vascular permeability from dynamic T2*-weighted imaging, a technique routinely used to measure cerebral blood volume (CBV) and flow in gliomas.
VASCULAR PERMEABILITY to a contrast agent is a potentially valuable measurement for evaluating cancer therapy efficacy and/or related normal tissue toxicity. Most pharmacokinetic modeling of vascular permeability is based upon dynamic contrast-enhanced (DCE) T1 MR measurements (1) (2) (3) . Although some concerns remain in the estimation of contrast agent concentrations using DCE T1 measures (4 -6) , the methodologies for permeability quantification have been reviewed and a consensus has been reached (7) . Interest in estimating vascular permeability to gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) from DCE T2*-weighted images has recently increased (8) , driven primarily by clinical research interests in obtaining perfusion parameters of cerebral blood volume (CBV) and cerebral blood flow (CBF), along with a measure of the vascular permeability estimate in a single bolus contrast injection. Single-shot T2*-weighted DCE is commonly utilized for whole-brain mapping of CBV and CBF, especially in clinical settings, due to its high temporal resolution (one to two seconds) and tissue coverage; whereas T1-sensitive DCE acquisition is desirable to measure permeability. Competing factors, however, make it difficult to accentuate both T1 and T2* contrast during the passage/leakage of an intravascular agent, so that typically only one contrast type is selected for a given injection. Ideally, two contrast injections are performed in separate series to independently determine permeability and blood volume/flow. This may add significant cost, scan time, and protocol complexity, and thus twoinjection MRI exams are usually not performed. As a potential practical alternative, estimation of CBV has been proposed from a T1-weighted DCE images series based on signal enhancement during the first pass of a bolus while it is still confined to the vasculature (9). This is not ideal, since T1-weighted techniques typically do not have the temporal and spatial resolution of T2*-weighted echo-planar imaging (EPI). In another approach, both T1-and T2*-sensitive images are simultaneously acquired by dual gradient-echo dynamic imaging (10, 11) , but this method requires a tradeoff between the temporal and spatial resolution. Conversely, contrast leakage into the extravascular space alters signal on T2*-weighted images so that it may be possible to derive vascular permeability by analysis of agent recirculation and equilibration during the latter time points of a dynamic T2*-weighted series (8) . The objective of the work presented here was to investigate the performance of a new algorithm for deriving permeability information from a dynamic T2*-weighted image series. While quantification of multiple vascular properties from a single injection has substantial practical appeal, the stability and accuracy of such measures performed on a voxel-by-voxel basis is difficult to predict without clinical trials. Moreover, a hybrid approach is not anticipated to exceed the performance of dedicated (i.e., two-injection) methods, but the tradeoffs may be tolerable and permit retrospective estimation of additional useful properties.
The theoretical framework for correction and ultimate utilization of T1 enhancement in predominately T2*-weighted images has been described by others (12) . Nevertheless, using T2*-weighted images to obtain stable and reproducible voxel-by-voxel estimates for blood-to-brain/tumor permeability to a MR contrast agent remains a challenge. A method proposed by Weisskoff et al (12) , and modifications of that work (13, 14) , were primarily designed to correct the influence of T1 enhancement on the estimate of CBV; the method was later used for the estimate of vascular permeability in a clinical application (15) . The effect of T1 enhancement on the estimate of CBV, however, can be substantially reduced by using T2* instead of T2 measures, long TR, small flip angle, and relatively low contrast dose. Note that in Weisskoff's methods, back-flux of the contrast agent from extravascular extracellular space (EES) to the vascular space was neglected; at high values of permeability, this can cause estimates to be biased toward lower values (6) . Several other methodologies have also been proposed to simultaneously quantify permeability and CBV from dual gradient-echo dynamic images (10, 11) . Again, in these studies, the back-flux of the tracer was neglected. As a drawback, dual gradient-echo dynamic imaging has limited speed, so the investigators often trade spatial resolution or coverage (one to two slices) for temporal resolution (ϳ1-2 seconds per frame).
A recent methodology (8) has been presented in which the contrast concentration-time curve was determined from normal white matter, the back-flux of the tracer from the EES to the vascular space was considered, and the difference between intravascular and extravascular contrast-induced susceptibilities was neglected. This approach was able to qualitatively differentiate pathologies with different vascular properties. However, the technique is very sensitive to signal-to-noise and fails to produce voxel-by-voxel permeability or CBV corrected for vessel leakage.
Combining elements from these earlier works, we propose an iterative approach to estimate, voxel-byvoxel, the permeability map and CBV map from dynamic T2*-weighted MR images. The algorithm is applied to estimate the transfer constant of Gd-DTPA and CBV in the brains of 12 patients with grade IV gliomas. The estimate of CBV by this technique is compared to that calculated by a conventional method (16) . The stability of the algorithm is assessed by simulated data. Results indicate the algorithm is insensitive to noise and can generate stable estimates of permeability and CBV on a voxel-by-voxel basis (17) .
MATERIALS AND METHODS

Theory
The total tissue concentration of an extracellular contrast agent can be described as (7)
where C denotes the tracer concentration, v depicts the fractional volume, subscripts t, p, and ees represent respectively tissue, plasma, and EES, K trans is the transfer constant of the agent influx from the plasma to the EES, and k ep is the tracer efflux rate from the EES to the plasma. The fractional volume of the EES can be determined from the ratio of K trans to k ep.
Bolus Shape Function
The first-pass bolus shape function has been described by a gamma variate g(t) plus an integral term (8, 12) :
where
In most proposals (8,10 -14) , the recirculation "bump" in the bolus shape function has been neglected. However, in almost all cases we have examined, the second pass closely follows the first pass (Fig. 1) . Neglecting the second pass can result in substantial errors in estimates of K trans (Fig. 1d) . Thus, an additional term that describes the second pass was added to the bolus shape function (Eq. [2] ) as
where tЈ 0 ,t half , and AЈ are parameters adjusted for the time shift, width, and amplitude, respectively, of the bolus' second pass.
Algorithm
Our fitting process consists of five steps:
1. Assume K trans is zero and v p is 1% in normal white matter (18, 19 
Fitting Eq. [5] to the data in volumes of interest (VOIs) of normal white matter yields eight parameters (␣, ␤, t 0 , and A for the first pass, and t 0 Ј, t half , and AЈ for the second pass) that describe the bolus shape function. 2. For the first estimate of v p in each voxel, a rapid increase in C t up to the peak of the first pass is assumed to be predominately due to contrast agent in the intravascular space. This assumption is consistent with the computation of the CBV by the conventional algorithm (16) . In addition, a possible time shift of the input function in a voxel is considered and quantified compared to that in normal white matter. However, the change in the width of the input function is omitted due to the fact that there is insufficient information to determine it. With these assumptions, the input function for each voxel can be written as:
Fitting the temporal data up to the peak of the first pass in a voxel using Eq. [6] yields an estimate of the parameters v p vox (1) and t 0 vox . 3. Before computing K trans , the presence of significant vascular leakage in each voxel is assessed. The difference of the total contrast concentration in a voxel and the contribution of the vascular volume to the concentration in the voxel (see Fig. 2 ) is determined by Figure 1 . Contrast concentration-time curves in normal white matter of three patients (a-c). Note that the recirculation of the contrast bolus follows the first pass very closely. The intensity of the recirculation "bump" is significantly greater than that in the tail (d). For various shapes of the contrast concentration-time curves, accurate fits (solid lines) can be obtained from Eqs.
[2]- [4] . If only the first pass is considered, the residual sum of squares of errors (d) can be an almost order magnitude greater than that of fitting both the first-and second-bolus passes (c). 
If Eq. [7] is significantly greater than zero, it indicates that K trans is detectable (discernable from noise). Otherwise, fitting K trans can cause unstable results and errors in both K trans and v p . Thus, a t-test is used to evaluate Eq. [7] . The mean and standard deviation (SD) of the different signals in Eq. [7] from the time at the peak of the first pass of the bolus to the end of the time curve are calculated. Then, a t-value is calculated as the ratio of the mean to the standard error of the mean (SEM). If the t-value is significantly greater than zero (onetailed t-test; P Ͻ 0.05), the computation continues for step 4, and if not, K trans and k ep are assigned to be zero and the program stops. 4. Fit Eq. [7] for the second half of the curve (starting from the peak) to obtain the first estimates of K trans (1) and k ep (1) 
MRI Experiment and Subjects
Retrospective analysis was performed on dynamic T2*-weighted images acquired in 12 patients with grade IV glioma participating in a clinical protocol approved by the internal review board. The images were acquired one to two weeks prior to radiotherapy, but two to four weeks after surgery (either partial resection or biopsy only). Informed consent was obtained from all of the patients prior to the study. All images were acquired on a 1.5-Tesla clinical MRI scanner (General Electric Medical Systems, Milwaukee, WI, USA). A total of 36 volumes of dynamic T2*-weighted images were acquired by a gradient-echo EPI pulse sequence with TR ϭ 2 seconds, TE ϭ 60 msec, field-of-view ϭ 220 ϫ 220 mm 2 , matrix size ϭ 128 ϫ 128, flip angle ϭ 60°, and 14 interleaved slices with thickness ϭ 6 mm and gap ϭ 0 mm. Gd-DTPA (0.1 mL/kg) was injected intravenously by a power injector with a rate of 2 mL/second, followed immediately by 15 mL of saline flush at the same rate.
The paramagnetic contrast agent that has been previously used for estimates of CBV and CBF (16, 20, 21) gives rise to a change in R 2 *, which has been (either implicitly or explicitly) assumed to be proportional to the intravascular contrast concentration (16, 20, 22) as
where ␥ intra is the proportional factor, and C p is the plasma contrast concentration. The effective R 2 * change in a voxel that contains both intravascular and extravascular contrast agents can be approximated as
where ␥ eff is the effective proportional factor, and C t is the total contrast concentration in tissue. Given that the R 2 * effect depends upon the size of the contrast distribution space (23), ␥ intra and ␥ eff may be different, and given the difficulty of constructing model systems representative of capillary vascular beds, not easily determined by in vitro studies. Using Eq. [1] , [8] , and [9] , the effective R 2 *change in a voxel can be expressed as
where Eq. [10] is similar to Eq. [1] , except that vЈ p and KЈ trans are scaled by the ratio of ␥ eff to ␥ intra . For a voxel that contains no leaky vessels, the ratio is equal to one. The ⌬R 2 * is obtained from the EPI sequence described previously as
where S o and S are the signal intensities acquired before and after the contrast bolus injection, respectively.
Numerical Computation
All software programs were developed in-house using Cϩϩ. Prior to computations for KЈ trans and vЈ p , acquisition time differences between sections within a single volume were corrected by cubic spline interpolation (24) to match the time of the first slice acquired in each volume. All of the fitting described in the Theory section was done by minimizing the residual sum of squares of errors using a simplex search algorithm (24) . To estimate the parameters (up to eight) of the input function, a typical VOI of normal white matter was selected, containing 500 -800 voxels that had a contrast-noise ratio (CNR) of 100 -150. CNR is defined as the difference in signal intensities between the peak of the first pass of the bolus and the baseline average divided by the SD of the baseline signal intensities. Several guidelines were used for selection of the white matter VOI: 1) normal appearance in T2-weighted images; 2) contralateral to the tumor; 3) as large as possible but avoiding partial volume averaging with gray matter and cerebrospinal fluid (CSF); and 4) avoiding regions degraded by susceptibility artifact. Also, voxels that had signal intensities 2SD above or below the mean were rejected from the VOI. To obtain the eight parameters of the input function, the residual sum of squares of errors from fitting the white matter VOI was minimized iteratively until the relative change between two subsequent iterations was less than 1 ϫ 10 -8 , a process which took about six to eight seconds. A similar iterative procedure was also applied to fit individual voxels, for which two parameters were fitted in step 2 ( p vox (1) and t 0 wox ) and step 4 (K trans (1) and k ep (1) ), and three parameters in step 5 (K trans , k ep , and v p ).
Stability Test
The stability of the fitting algorithm is crucial for its usefulness in a clinical trial. Thus, the stability was tested by computer simulated data, in which v p was 1%, K trans varied from 0.001 to 0.5 minute -1 , and v ees was 15%. For the clinical data obtained, the single-voxel CNR in the tumor varied from 18 to 50. Thus, Gaussian noise was added to the simulated contrast concentration-time curves to have CNR of 20, 50, 100, and infinite at the peak of the first passage of the bolus. The simulated contrast concentration-time curve contained 36 points with two seconds per point, which matched the clinical data that we obtained. For each combination of the tested parameters and noise levels, 4096 simulations were conducted. The SD of the 4096 simulations per condition was computed and was used as a metric to assess the stability of the algorithm.
RESULTS
Contrast concentration-time curves in the normal white matter of three patients, and their fitting results using Eqs. [2] - [4] , are shown in Fig. 1 . If the recirculation pass is ignored, there is substantial discrepancy between the fitting result and the empirical data (Fig.  1d) . For the example shown in Fig. 1c and d , the residual sum of squares of errors obtained by fitting the first pass only was 1.1 ϫ 10 -3 , almost an order of magnitude greater than the value of 1.4 ϫ 10 -4 that was obtained by fitting both the first and second passes (Fig. 1c) . This error affects the estimate of KЈ trans . The KЈ trans value obtained by fitting both the first and second passes of the bolus was approximately 22% greater than that obtained by fitting the first pass only (Fig. 2) ; while estimates of vЈ p obtained by the two fittings were very close (Ͻ3% in difference), as expected. For the case shown in Fig. 2 , the mean KЈ trans in the tumor volume defined on the fluid attenuation inversion recovery (FLAIR) images were 0.028 and 0.023 minute -1 with and without fitting the recirculation "bump," respectively.
In our algorithm, after the initial estimates of v p and t 0 vox for an individual voxel or VOI (step 2), the difference between a total of the contrast concentration and the intravascular concentration described by Eq. [7] was evaluated to determine whether there was a significant extravascular contrast concentration, defined as the area under the temporal curve after the first-pass peak significantly differing from zero (Fig. 3b) . The extravascular contrast concentration-time curves from a VOI and a voxel in the tumor volume were significantly greater than zero (P Ͻ 0.05), while the data from another VOI and a voxel in the region contralateral to tumor were not (P Ͼ 0.05). For the latter VOI and voxel, KЈ trans was assigned to be zero. For the first VOI and voxel, the fitting procedure continued to steps 4 and 5. An example of KЈ trans and vЈ p (CBV) maps in a patient with grade IV glioma reconstructed by our algorithm is shown in Fig. 4 . Note that only the rim of the tumor has significant nonzero KЈ trans . CBV maps reconstructed by our algorithm are similar to the CBV estimated by the conventional method without correction for vascular leakage (Fig. 5) (16) . A scatter-plot of the two CBV maps shown in Fig. 5c has a correlation coefficient of 0.83, slope of 0.86, and intercept of 0.27%. As expected, the relative differences of the two CBV maps are similar to the KЈ trans maps (Fig. 5) . Particularly, in the tumor region, the CBVs estimated by our algorithm are smaller than those obtained by the conventional method; in the latter, extravascular contrast agent, is at least partially accounted for as intravascular contrast agent.
In the 12 patients with grade IV gliomas, the averaged KЈ trans over the tumor volume that was defined on FLAIR images but excluding voxels having zero KЈ trans Plots show the differences of a total of the contrast concentrations and the intravascular contributions to the concentration, presumably the extravascular tracer concentrations described by Eq. [7] , in the two VOIs and two voxels. c: Shows the locations of the two VOIs and the two voxels, and arrows point to the voxels. Note that only the differences from the VOI and the voxel in the tumor region are significantly greater than zero (P Ͻ 0.05), whereas those from the region contralateral to tumor are not.
(Ͻ0.0002 minute -1 ) ranged from 0.12 minute -1 to 0.02 minute -1 , the group mean of 0.07 minute -1 Ϯ 0.03 minute -1 . Similarly, the average vЈ p over the tumor volume ranged from 4.7% to 1.7%, with a group mean of 2.7%Ϯ 0.9% (Table 1) . SDs of KЈ trans in individual tumors are also given in Table 1 , and are on the order of magnitude of KЈ trans itself, suggesting heterogeneous vascular leakage in the tumor volume.
The stability of the algorithm was tested by computer simulated data. For K trans of 0.5 to 0.02 minute -1 and four different CNRs, the ratio of the SD to the mean was less than 7%. For K trans of 0.01 minute -1 , the ratio was less than 11%, while for 0.005 minute -1 , the ratio was less than 33%. For K trans of 0.002 and 0.001 minute -1 , the ratio was less than 33% for CNR greater than or equal to 50 and was greater than 100% for CNR of 20 (Fig. 6) .
DISCUSSION
Accurately and consistently fitting the shape of the input function from normal white matter is crucial to minimize the error in voxel-by-voxel estimates of the transfer constant based upon dynamic T2*-weighted images. As demonstrated in Fig. 1 , our algorithm eliminates the error associated with second-pass contrast recirculation. Successfully fitting the contrast agent recirculation reduced the residual sum of squares of errors by almost an order of magnitude compared to neglecting the recirculation. This error can greatly impact the estimate of the transfer constant, which is approximately 22% underestimated, as evidenced in Fig. 2 . In order to fit the second pass, three additional parameters (AЈ, t 0 Ј, and t half ) were introduced to describe the width, height, and onset time of the second pass. Although there are up to eight parameters involved in fitting the input function from white matter, the CNR (approximately 150 at the peak of the curve) of the normal white matter curve obtained from a VOI that typically contains 500 -800 voxels is sufficient for fitting. If in the case that there is no recirculation bump (we saw one such case out of 12 patients), AЈ (the amplitude of the recirculation bump) can be either manually or automatically set to zero. The ability to detect these eight parameters, although they are independent, can be influenced by the temporal resolution and the signal-to-noise ratio of the input function. However, it is worthwhile to point out that the accuracy in the fitting of the shape of the input function, determined by the mean squares error, affects the subsequent estimates of the transfer constant and the blood volume, but the precision of the individual parameters of the input function do not. Also, when the eight parameters are fitted, the shape of the input function is determined and is not altered (expect a possible time-shift) in the fitting for the transfer constant and the blood volume. Given the single-voxel CNR of 18 -50 (at the peak of the curve) that typically can be achieved in dynamic T2*-weighted images on a 1.5-T scanner, a few steps in our algorithm are crucial to obtaining stable voxel-byvoxel estimates of the transfer constant and CBV. First, the difference in the width of the input function in a voxel from that in normal white matter is omitted. This omission is due to several considerations: 1) limited CNR; 2) limited temporal resolution; and 3) a broadening in the width of the contrast concentration-time curve in a voxel could also possibly be caused by vascular leakage (Fig. 3a) . Thus, if the width of the input function for each voxel is allowed to vary freely, instability in fitting might result. On the other hand, the time shift of the input function in each voxel can be determined relatively easily from the initial, rapidly rising part of the curve, and there is no other parameter competing for this information (Fig. 3) . Thus, the time-shift is adjusted for each voxel. Second, the initial voxel-byvoxel estimate of v p (step two) is on principle similar to the conventional CBV estimation when there is no vascular leakage and no width change of the input function in the voxel (16) . The second part of the curve (after the peak of the first pass), including the broadening and elevation of the curve, is used for the initial estimates of KЈ trans and k ep . Third, an iterative process is used to readjust vЈ p , KЈ trans and k ep , since for a voxel that contains leaky vessels vЈ p is potentially overestimated in step 2 and subsequently KЈ trans is underestimated in step 4.
CBV as estimated by our algorithm is well correlated with that obtained from the conventional method (Fig.  5) . The major differences between the two CBV maps are located in the regions with tumor and/or large vessels (Fig. 5d) . Interestingly, but as expected, the pattern of the difference of the two CBV maps qualitatively resembles that of the transfer constant (Fig. 5e ). In the brain and/or tumor regions where blood-brain/tumor barriers are disrupted and there is tissue uptake of the contrast agent, the contrast concentration-time curves are in general broadened and elevated (see Fig. 3a) , which have been assigned partially if not completely to be a part of CBV by the conventional method. Our algorithm attributes the broadened and elevated contrast concentration-time curves in tissue (compared to that in normal white matter) to vessel leakage, and consequently the transfer constant of the contrast agent is estimated.
The averaged transfer constants of Gd-DTPA in the grade IV glioma volumes ranged from 0.02 to 0.12 minute -1 with a group mean of 0.07 minute -1 , which is in the range of the values reported in the literature. In a group of 10 patients with glioblastoma multiforme, Johnson et al (8) found a mean transfer constant of 0.09 minute -1 using dynamic T2*-weighted images and fitting the first pass only in the regions of interest (ROIs). In that study, the transfer constants were estimated within selected ROIs that showed the greatest signal changes during the bolus arrival; whereas in our study the transfer constants that were estimated voxelby-voxel were averaged over the voxels having nonzero transfer constants (Ͼ0.0002 minute -1 ) but within the tumor volume. The heterogeneity of the transfer constants in grade IV gliomas is well presented in Table 1 , in which the SD is almost as great as the mean for each of the tumors. In 22 patients with gliomas, Roberts et al (25) reported the significant correlation between grades determined histologically and Gd-DTPA transfer constants estimated by using a T1-based approach and selecting the ROIs. If only grade IV gliomas in Robert et al's (25) study are considered, the averaged transfer constant was 0.094 minute -1 (N ϭ 6), ranging from 0.4 to 0.13 minute -1 , essentially in agreement with our estimates. Using a modified T1 approach, Li et al (9) estimated that transfer constants ranged from 0.07 to 0.01 minute -1 , which were relatively smaller those reported by Roberts et al (25) , Johnson et al (8) , and us. Based upon our simulated data, the SD in estimates of the transfer constant increased with noise and with a decreased of the transfer constant (Fig. 6) . For the 12 patients, the smallest averaged transfer constant in the FLAIR tumor volume is 0.021 minute -1 . For the transfer constant Ն0.02 minute -1 , our simulated data suggest that the ratio of the SD to the mean of the transfer Figure 6 . The ratio of the SD to the mean of the transfer constant as a function of the contrast to noise ratio at the peak of the first pass of the bolus. constant is less than 6%. This indicates that the heterogeneity of the transfer constant in the tumor volume is not predominantly due to noise. It is difficult to differentiate susceptibility induced by extravascular contrast from that arising form intravascular paramagnetic contrast (26) . The relationship between the contrast concentration and induced susceptibility is complex, and may be influenced by the contrast distribution. Therefore, in vitro calibration is difficult to apply to in vivo data. The contrast agents distributed in the extravascular extracellular space most likely induce a T2* effect smaller than the contrast contained in microvasculature (23) . As a result, neglecting this difference between intravascular and extravascular contrast-induced susceptibilities may cause an underestimation of the transfer constant.
In our computation, T1 enhancement (12) is not taken into account. Our data were acquired with long TR (two seconds), long TE (60 msec), 60°RF pulse, and low contrast dose, and the signals never became negative within the 72 seconds acquisition time. Thus, T1 enhancement is a small effect, and most likely negligible. In step 3 of our algorithm, the contrast concentration-time curve in each voxel was compared to that in normal white matter after normalization by the first estimate of CBV. Only the voxels that show significant broadening and elevation after the peak of the first pass of the bolus compared to that in normal white matter are considered to have nonzero leakage. This step avoids fitting the transfer constant in the voxels where the contrast concentration-time curve after subtracting the intravascular contribution exhibits more noise than signal (see Fig. 3b ), since such fitting can result in large errors in both the estimates of the CBV and the transfer constant and can cause instability.
The proposed algorithm shows excellent stability. For the single-voxel CNR of 20 or better that is routinely obtained in clinic, our simulation shows that the ratio of the SD to the mean is 11% or better for the transfer constant greater than or equal to 0.01 minute -1 . For the transfer constant of 0.005 minute -1 , the ratio increases to 33% for CNR of 20. This latter increase in the SD of simulation reflects the detectability for small transfer constants using the current image acquisition parameters rather than the stability of the algorithm. The detectability can be improved by increasing data acquisition time to allow the contrast to infuse into tissue without an increase in CNR. For example, if the acquisition time is increased by 20 seconds, the ratio of the SD to the mean decreases from 33% to14% for the transfer constant of 0.005 minute -1 and CNR of 20. In conclusion, the excellent stability of our algorithm is essential for using vascular permeability as a metric to evaluate a therapeutic regime (e.g., antiangiogenesis and antitumor) in a clinical trial. This algorithm allows us to retrospectively estimate the transfer constant of vasculature to Gd-DTPA from the dynamic T2*-weighted images that are widely used for estimates of CBV and CBF in brain tumor clinic trials. Using a single image acquisition, the three most important vascular properties, CBV, CBF, and permeability, can be estimated, thus avoiding two contrast injections. Our approach may also have potential in clinical evaluation of patients with acute ischemic stroke, in which patient population a blood-brain-barrier (BBB) permeability increase can be an indicator of acute hemorrhage.
